Skip to content

Category: Biotechnology

OncoSil Medical (ASX:OSL) Tender Process for CRO to Undertake G-BA Study Commences

By API User

Sydney, Australia – 30 April 2025: Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) (“OncoSil” or “the Company”) is pleased to announce that the Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) in Germany has officially initiated a European-wide tender process to identify and appoint a Contract Research Organisation (CRO). The selected CRO will be responsible … Continued

Optiscan Imaging (ASX:OIL) Quarterly Activities and Cash Flow Report

By API User

Highlights for the Quarter • Optiscan revealed InForm™, its next generation microscopic medical imaging device specifically designed for pathology workflows. • Optiscan received $1.775m R&D tax refund, $1.0m more than in previous years, due to the successful Advance and Overseas Finding application. • A comprehensive review of operations, sales and marketing functions, and clinical and regulatory strategy occurred, … Continued

OncoSil Medical Achieves Record Quarterly Dose Sales in Q3 FY25

By API User

Key Highlights • Record quarterly dose sales reported in the March 2025 quarter, on the back of continued growth in clinical adoption of the OncoSil™ device • Advisory Board Meetings in UK and Germany define strategic pathways for OncoSil™ device • OncoSil Medical receives $1.05m R&D tax incentive • Ms Lel Smits appointed to OncoSil Medical Board of … Continued

Australian stem cell researchers win prestigious international award

By API User

Magellan Stem Cell researchers have been honoured with a Research Publication of the Year Award by a prestigious international medical journal. The Melbourne-based researchers won the Osteoarthritis and Cartilage Open Clinical Research Publication of the Year Award for the excellence of their original research.   The results of  Magellan’s Phase I/IIa trials of Magellan’s off-the-shelf … Continued

CLEO to Fast Track Development of Ovarian Cancer Test

By API User

Highlights CLEO signs Collaboration Agreement with University College London (UCL) to accelerate test development, securing access to ~2,000 high-quality blood samples Samples sourced from UKCTOCS, the world’s largest Ovarian Cancer screening trial, to strengthen CLEO’s clinical validation program Collaboration with UCL and renowned Ovarian Cancer expert, Professor Usha Menon, will evaluate CLEO’s technology in two clinical studies focussed on … Continued

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

By API User

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related … Continued

ReNerve Expands Global Footprint with Strategic Partnership for Indian Market

By API User

Melbourne, Australia – 10 April 2025 | ReNerve Limited (ASX: RNV) (“ReNerve” or the “Company”), an Australian medical device company specialising in peripheral nerve repair technologies, is pleased to announce it has entered into a strategic partnership with NetCentrix Ventures to establish and expand its operations in the Indian healthcare market. This agreement marks a … Continued

Optiscan Imaging (ASX:OIL) Optiscan to Showcase Imaging Tech at Site Tour

By API User

During the visit, attendees will receive a detailed overview of Optiscan’s strategic direction, commercialisation progress, and key milestones across its three core markets: • Medical – advancing real-time digital pathology and precision surgery• Veterinary – expanding imaging capabilities into animal healthcare • Life Sciences – enabling high-resolution live-cell imaging in preclinical research  The visit will include live … Continued

Optiscan Imaging (ASX:OIL) Announces New CFO & Other Executive Appointments

By API User

These senior executive team changes mean Optiscan is now better resourced to implement its transformation plan and future-focussed priorities. Highlights • Optiscan’s current Finance Manager, Mr Darius Ooi, has been promoted to the Chief Financial Officer role, and will now lead the Corporate team. • Ms Belinda Williamson has been appointed as Chief Commercial Officer, and … Continued

BlinkLab Limited Surpasses Key Milestone in Pivotal US Autism Diagnostic Trial

By API User

Perth, Australia – 1 April 2025 | BlinkLab Limited (ASX: BB1) (“BlinkLab” or the “Company”) is pleased to announce it has successfully recruited 54 children as participants, surpassing the halfway point of the initial 100-patient phase of its pivotal U.S. clinical trial to validate the Company’s AI-powered smartphone-based autism diagnostic tool. The trial is part … Continued